Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Aug;40(2):300–323. doi: 10.1038/bjc.1979.179

Proceedings of the British Association for Cancer Research. University of Glasgow 28--30 March 1979. Abstracts.

PMCID: PMC2010021  PMID: 38824

Full text

PDF
300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bender M. A., Griggs H. G., Bedford J. S. Mechanisms of chromosomal aberration production. 3. Chemicals and ionizing radiation. Mutat Res. 1974 May;23(2):197–212. doi: 10.1016/0027-5107(74)90140-7. [DOI] [PubMed] [Google Scholar]
  2. Connors T. A., Goddard P. M., Merai K., Ross W. C., Wilman D. E. Tumour inhibitory triazenes: structural requirements for an active metabolite. Biochem Pharmacol. 1976 Feb 1;25(3):241–246. doi: 10.1016/0006-2952(76)90207-0. [DOI] [PubMed] [Google Scholar]
  3. DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dosogne-Guérin M., Stolarczyk A., Borkowski A. Prospective study of the alpha and beta subunits of human chorionic gonadotrophin in the blood of patients with various benign and malignant conditions. Eur J Cancer. 1978 May;14(5):525–532. doi: 10.1016/0014-2964(78)90255-4. [DOI] [PubMed] [Google Scholar]
  5. Freshney R. I., Morgan D. Radioisotopic quantitation in microtitration plates by an autofluorographic method. Cell Biol Int Rep. 1978 Jul;2(4):375–380. doi: 10.1016/0309-1651(78)90023-1. [DOI] [PubMed] [Google Scholar]
  6. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  7. Laing L., Smith M. G., Calman K. C., Smith D. C., Leake R. E. Nuclear oestrogen receptors and treatment of breast cancer. Lancet. 1977 Jul 23;2(8030):168–169. doi: 10.1016/s0140-6736(77)90183-0. [DOI] [PubMed] [Google Scholar]
  8. Levy L., Harris R. Effect of N-acetylcysteine on some aspects of cyclophosphamide-induced toxicity and immunosuppression. Biochem Pharmacol. 1977 Jun 1;26(11):1015–1020. doi: 10.1016/0006-2952(77)90237-4. [DOI] [PubMed] [Google Scholar]
  9. Loveless A. Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature. 1969 Jul 12;223(5202):206–207. doi: 10.1038/223206a0. [DOI] [PubMed] [Google Scholar]
  10. Masters J. R., Sangster K., Hawkins R. A., Shivas A. A. Elastosis and oestrogen receptors in human breast cancer. Br J Cancer. 1976 Mar;33(3):342–343. doi: 10.1038/bjc.1976.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miller W. R., Forrest A. P. Oestradiol synthesis from C19 steroids by human breast cancers. Br J Cancer. 1976 Jan;33(1):116–118. doi: 10.1038/bjc.1976.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Norton L., Simon R. Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep. 1977 Oct;61(7):1307–1317. [PubMed] [Google Scholar]
  13. Nunn M. E., Djeu J. Y., Glaser M., Lavrin D. H., Herberman R. B. Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma. J Natl Cancer Inst. 1976 Feb;56(2):393–399. doi: 10.1093/jnci/56.2.393. [DOI] [PubMed] [Google Scholar]
  14. Paladine W., Cunningham T. J., Sponzo R., Donavan M., Olson K., Horton J. Intracavitary bleomycin in the management of malignant effusions. Cancer. 1976 Nov;38(5):1903–1908. doi: 10.1002/1097-0142(197611)38:5<1903::aid-cncr2820380506>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  15. Povlsen C. O., Skakkebaek N. E., Rygaard J., Jensen G. Heterotransplantation of human foetal organs to the mouse mutant nude. Nature. 1974 Mar 15;248(445):247–249. doi: 10.1038/248247a0. [DOI] [PubMed] [Google Scholar]
  16. Puri H. C., Campbell R. A. Cyclophosphamide and malignancy. Lancet. 1977 Jun 18;1(8025):1306–1306. doi: 10.1016/s0140-6736(77)91336-8. [DOI] [PubMed] [Google Scholar]
  17. Rickwood D., Riches P. G., Maggillivray A. J. Studies of the in vitro phosphorylation of chromatin non-histone proteins in isolated nuclei. Biochim Biophys Acta. 1973 Feb 23;299(1):162–171. doi: 10.1016/0005-2787(73)90408-5. [DOI] [PubMed] [Google Scholar]
  18. Roberts J. J., Pascoe J. M. Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds. Nature. 1972 Feb 4;235(5336):282–284. doi: 10.1038/235282a0. [DOI] [PubMed] [Google Scholar]
  19. Roizin-Towle L., Hall E. J. Studies with bleomycin and misonidazole on aerated and hypoxic cells. Br J Cancer. 1978 Feb;37(2):254–260. doi: 10.1038/bjc.1978.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sanui H., Rubin A. H. Membrane bound and cellular cationic changes associated with insulin stimulation of cultured cells. J Cell Physiol. 1978 Sep;96(3):265–278. doi: 10.1002/jcp.1040960302. [DOI] [PubMed] [Google Scholar]
  21. Schoental R., Joffe A. Z., Yagen B. Irreversible depigmentation of dark mouse hair by T-2 toxin (a metabolite of Fusarium sporotrichioides) and by calcium pantothenate. Experientia. 1978 Jun 15;34(6):763–764. doi: 10.1007/BF01947311. [DOI] [PubMed] [Google Scholar]
  22. Shivas A. A., Douglas J. G. The prognostic significance of elastosis in breast carcinoma. J R Coll Surg Edinb. 1972 Sep;17(5):315–320. [PubMed] [Google Scholar]
  23. Shortman K., Jackson H. The differentiation of T lymphocytes. I. Proliferation kinetics and interrelationships of subpopulations of mouse thymus cells. Cell Immunol. 1974 May;12(2):230–246. doi: 10.1016/0008-8749(74)90075-6. [DOI] [PubMed] [Google Scholar]
  24. Stratford I. J., Adams G. E. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man. Br J Radiol. 1978 Sep;51(609):745–746. doi: 10.1259/0007-1285-51-609-745. [DOI] [PubMed] [Google Scholar]
  25. Szumiel I., Nias A. H. Action of a platinum complex [cis-dichlorobis (cyclopentylamine)-platinum (II)] on Chinese hamster ovary cells in vitro. Chem Biol Interact. 1976 Aug;14(3-4):217–232. doi: 10.1016/0009-2797(76)90102-2. [DOI] [PubMed] [Google Scholar]
  26. Watson J. V., Chambers S. H. Nucleic acid profile of the EMT6 cell cycle in vitro. Cell Tissue Kinet. 1978 Jul;11(4):415–422. doi: 10.1111/j.1365-2184.1978.tb00813.x. [DOI] [PubMed] [Google Scholar]
  27. Woods K. L., Heath D. A. The radioimmunoassay of human lactalbumin. Clin Chim Acta. 1977 Jul 1;78(1):129–133. doi: 10.1016/0009-8981(77)90345-x. [DOI] [PubMed] [Google Scholar]
  28. von Ardenne M. Selective multiphase cancer therapy: conceptual aspects and experimental basis. Adv Pharmacol Chemother. 1972;10:339–380. doi: 10.1016/s1054-3589(08)60527-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES